LinkDoc Secures Strategic Investment from Ali Health

(VCBeat) Mar. 4, 2021 -- LinkDoc Technology ("LinkDoc"), a Chinese company focusing on big data in medicine, recently announced it has received a strategic investment from Ali Health. The two companies will build a patient-centered and technological innovation-driven full-disease cycle service platform for Chinese oncology patients, actively explore innovative online service mode of oncology specialty drugs, and create an online and offline oncology specialty medical service system, to provide patients with high-quality medical services covering the entire disease cycle, from treatment to medicine.

Under the background of encouraging the innovative development of medical and healthcare enterprises, Ali Health actively expands its business to meet the diversified medical and healthcare needs of more patients. With the "Internet + Medicine" strategy, Ali Health has established a reliable and inclusive medical service system. Through the layout of "having good drugs, famous doctors and guarantee", Ali Health uses the Internet model and technological innovation to promote the development of scientific research, diagnosis and treatment of major diseases, genetic testing, biological vaccines, and other fields.

This strategic investment in LinkDoc is Ali Health's new scheme in the field of major diseases, which demonstrates Ali Health's determination to promote medical care of serious diseases with innovative Internet technologies.

LinkDoc is committed to the R&D of big data and artificial intelligence (AI). With the mission of "Care Data Care Life", LinkDoc provides the overall solution of big data and AI for all parties in the pharmaceutical and medical industry. At present, its main business includes real-world pharmaceutical researches, patient health management, patient recruitment, etc. The company also focuses on providing solutions in the field of major diseases, especially oncology and rare diseases.

After this round of financing, LinkDoc will connect all kinds of online and offline resources to establish a service loop, and benefit more patients, based on its advantages in data management, auxiliary diagnosis and treatment, scientific research services, patient management, doctor operation, and drug distribution in the vertical field of oncology.